Home
Acute Ischemic Stroke
Unmet Clinical Need
Our Solution
The Team
Our Company
Careers
IN THE NEWS
Contact Us
Privacy Policy
Close (Esc)
Unit 6, Galway Business Park, Dangan
Galway,
H91 W7CP,
Ireland
News Signup
NEXT GENERATION STROKE TECHNOLOGY
Perfuze is developing innovative medical technology for clot removal in stroke patients
INNOVATION
Scroll to Explore
References
(1) World Stroke Organisation www.world-stroke.org
2020
(2) Mozaffarian et al. Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association.
Circulation
2015
ABOUT ISCHEMIC STROKE
Stroke is the second leading cause of death and is the leading cause of adult disability.
1,2
Over 13 million people worldwide will have a stroke this year and more than 5 million people will die as a result.
1,2
Learn More
RESEARCH
References
(3) Nogueira et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct.
N. Engl. J. Med.
2016
(4) Goyal et al. Endovascular Thrombectomy after Large-Vessel Ischaemic Stroke: A Meta-Analysis of Individual Patient Data from Five Randomised Trials.
The Lancet
2016
UNMET CLINICAL NEED
Despite recent clinical advances in stroke therapy, less than 50% of stroke patients treated today achieve a positive clinical outcome.
3,4
Learn More
TECHNOLOGY
Video Button Icon
Watch Full Video
THE SOLUTION
Learn More
OUR COMPANY
Perfuze was founded in 2018 by Wayne Allen and Liam Mullins and are located in Galway City in the West of Ireland.
The Team
Careers
Knowledge